The share capital of Onxeo S.A. has been increased. The admittance to trading
and official listing will take effect as per 5 July 2017 in the ISIN below.
ISIN: FR0010095596 ------------------------------------------------------------ Name Onxeo ------------------------------------------------------------ Volume before change: 47,043,404 shares (EUR 11,760,851) ------------------------------------------------------------ Change: 3,529,11 shares (EUR 882,352.75) ------------------------------------------------------------ Volume after change: 50,572,815 shares (EUR 12,643,203.75) ------------------------------------------------------------ Subscription price: EUR 4.25 ------------------------------------------------------------ Face value: EUR 0.25 ------------------------------------------------------------ Short name: ONXEO ------------------------------------------------------------ Orderbook ID: 101775 ------------------------------------------------------------
For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66
Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=637209
ISIN: FR0010095596 ------------------------------------------------------------ Name Onxeo ------------------------------------------------------------ Volume before change: 47,043,404 shares (EUR 11,760,851) ------------------------------------------------------------ Change: 3,529,11 shares (EUR 882,352.75) ------------------------------------------------------------ Volume after change: 50,572,815 shares (EUR 12,643,203.75) ------------------------------------------------------------ Subscription price: EUR 4.25 ------------------------------------------------------------ Face value: EUR 0.25 ------------------------------------------------------------ Short name: ONXEO ------------------------------------------------------------ Orderbook ID: 101775 ------------------------------------------------------------
For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66
Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=637209